Delayed
Hong Kong S.E.
04:08:06 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
0.058
HKD
|
-.--%
|
|
+9.43%
|
-22.67%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
3,547
|
859.8
|
257.9
|
467.4
|
303.8
|
303.8
|
Enterprise Value (EV)
1 |
4,577
|
2,360
|
1,928
|
2,247
|
2,079
|
2,047
|
P/E ratio
|
-24.3
x
|
-1.78
x
|
-0.35
x
|
-0.17
x
|
-0.85
x
|
-1.87
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.57
x
|
0.89
x
|
0.3
x
|
0.72
x
|
0.22
x
|
0.23
x
|
EV / Revenue
|
9.77
x
|
2.44
x
|
2.28
x
|
3.45
x
|
1.54
x
|
1.58
x
|
EV / EBITDA
|
124
x
|
-37.4
x
|
-19.1
x
|
-1.79
x
|
-20.2
x
|
-37.9
x
|
EV / FCF
|
13.3
x
|
-5.96
x
|
-61.8
x
|
3.55
x
|
10.1
x
|
25.6
x
|
FCF Yield
|
7.52%
|
-16.8%
|
-1.62%
|
28.1%
|
9.9%
|
3.91%
|
Price to Book
|
1.14
x
|
0.34
x
|
0.15
x
|
-0.58
x
|
-0.27
x
|
-0.23
x
|
Nbr of stocks (in thousands)
|
1,074,769
|
1,074,769
|
1,074,769
|
1,168,519
|
1,168,519
|
1,168,519
|
Reference price
2 |
3.300
|
0.8000
|
0.2400
|
0.4000
|
0.2600
|
0.2600
|
Announcement Date
|
4/26/18
|
4/30/19
|
6/28/20
|
2/23/23
|
3/31/23
|
5/30/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
468.6
|
967.1
|
846.6
|
650.9
|
1,350
|
1,296
|
EBITDA
1 |
37.04
|
-63.14
|
-100.8
|
-1,257
|
-102.8
|
-53.95
|
EBIT
1 |
-73.47
|
-270.8
|
-871.3
|
-3,082
|
-157.6
|
-115.5
|
Operating Margin
|
-15.68%
|
-28%
|
-102.92%
|
-473.47%
|
-11.67%
|
-8.92%
|
Earnings before Tax (EBT)
1 |
-194.5
|
-608
|
-1,158
|
-3,502
|
-460.1
|
-245.9
|
Net income
1 |
-145.8
|
-484
|
-742.7
|
-2,606
|
-357.7
|
-162.6
|
Net margin
|
-31.11%
|
-50.05%
|
-87.73%
|
-400.3%
|
-26.49%
|
-12.55%
|
EPS
2 |
-0.1360
|
-0.4503
|
-0.6911
|
-2.342
|
-0.3061
|
-0.1392
|
Free Cash Flow
1 |
344.1
|
-396.3
|
-31.17
|
632.3
|
205.8
|
79.99
|
FCF margin
|
73.44%
|
-40.97%
|
-3.68%
|
97.14%
|
15.24%
|
6.17%
|
FCF Conversion (EBITDA)
|
929.16%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/18
|
4/30/19
|
6/28/20
|
2/23/23
|
3/31/23
|
5/30/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
1,030
|
1,500
|
1,670
|
1,779
|
1,775
|
1,743
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
27.81
x
|
-23.76
x
|
-16.56
x
|
-1.415
x
|
-17.27
x
|
-32.3
x
|
Free Cash Flow
1 |
344
|
-396
|
-31.2
|
632
|
206
|
80
|
ROE (net income / shareholders' equity)
|
-4.51%
|
-13.4%
|
-34.9%
|
-378%
|
44.2%
|
17.7%
|
ROA (Net income/ Total Assets)
|
-0.82%
|
-2.62%
|
-9.44%
|
-53.4%
|
-4.72%
|
-3.49%
|
Assets
1 |
17,803
|
18,464
|
7,866
|
4,880
|
7,574
|
4,656
|
Book Value Per Share
2 |
2.890
|
2.320
|
1.630
|
-0.6800
|
-0.9800
|
-1.140
|
Cash Flow per Share
2 |
0.1500
|
0.1100
|
0.0200
|
0.0100
|
0.0200
|
0.0100
|
Capex
1 |
1.75
|
70.3
|
73
|
109
|
77.7
|
89
|
Capex / Sales
|
0.37%
|
7.26%
|
8.62%
|
16.7%
|
5.75%
|
6.87%
|
Announcement Date
|
4/26/18
|
4/30/19
|
6/28/20
|
2/23/23
|
3/31/23
|
5/30/23
|
|
1st Jan change
|
Capi.
|
---|
| -22.67% | 92.72M | | -21.48% | 1.71B | | +2.39% | 1.11B | | -10.54% | 607M | | +44.04% | 583M | | +24.78% | 528M | | +11.04% | 265M | | -27.77% | 256M | | +14.62% | 212M | | -4.57% | 187M |
Commodity Chemicals Wholesale
|